GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aptamer Group APTA.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

0.28p

-3.51%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

£1.5m

FY2019FY2026

Net income

−£1.9m

FY2019FY2026

Free cash flow

−£2.3m

FY2019FY2026

Shareholders' equity

£5.7m

FY2019FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue£1.5m£1.2m£860,000£1.8m£4.0m£1.3m£854,568£986,661
Gross profit£573,000£350,000£250,000£359,000£2.7m£538,400£455,970£612,852
Research and development£495,000£305,000£317,000£474,000£848,000£491,200£170,459£63,081
Operating income−£2.9m−£2.7m−£3.1m−£8.2m−£2.6m−£2.3m−£922,050−£540,244
Net income−£1.9m−£2.4m−£3.0m−£7.8m−£2.1m−£1.8m−£674,730−£454,984
Diluted earnings per share-0.00-0.00-0.01-0.02-0.03-0.03-0.01-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets£7.2m£2.8m£2.8m£2.8m£11.5m£2.1m£1.4m£1.4m
Cash and short-term investments£4.4m£1.1m£870,000£234,000£6.7m£369,000£293,148£727,159
Total liabilities£1.4m£1.5m£1.9m£2.4m£3.5m£2.0m£1.1m£497,255
Debt£170,000£491,000£817,000£1.1m£1.3m£78,000£160,978£71,570
Shareholders' equity£5.7m£1.4m£887,000£304,000£8.1m£105,000£245,806£899,871
Shares outstanding2,843m2,632m415m359m69m69m69m69m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−£2.1m−£2.0m−£2.3m−£4.1m−£2.4m−£1.1m−£82,712−£844,933
Capital spending−£172,000−£10,000−£122,000−£2.0m−£418,000−£157,600−£160,828−£40,820
Free cash flow−£2.3m−£2.0m−£2.4m−£6.1m−£2.8m−£1.3m−£243,540−£885,753

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023
Revenue£716,000£828,000£550,000£653,000£562,000£298,000£149,000£737,000
Gross profit£233,000£340,000£98,000£367,000£143,000−£26,000−£13,000−£97,000
Operating income−£1.6m−£1.3m−£1.4m−£1.2m−£1.3m−£1.9m−£936,000−£2.6m
Net income−£714,000−£1.1m−£1.3m−£1.1m−£1.2m−£1.8m−£903,500−£5.2m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.01-0.00-0.01
Cash from operations—−£1.0m—−£1.0m—−£1.0m—−£1.0m
Total assets£7.2m£3.7m£2.8m£4.3m£2.8m£4.0m£4.0m£8.6m
Cash and short-term investments£4.4m£1.5m£1.1m£2.0m£870,000£1.8m£1.8m£1.9m
Debt£161,000£257,000£249,000£242,000£262,000£426,000£99,000£333,000
Shareholders' equity£5.7m£2.3m£1.4m£2.6m£887,000£2.0m£2.0m£5.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.1%3.8%—
Operating income-29.6%4.4%—
Net income-38.1%0.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.6%28.6%44.5%—
Operating margin-202.0%-313.3%-202.9%—
Net margin-156.0%-281.4%-178.2%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings-4.3-11.7-0.5-0.2-1.6-4.9
Price to sales5.323.51.81.10.87.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.